首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

2075418

沙門氏菌檢測市場：按檢測方法、檢體類型、應用、最終用戶和地區分類。

Salmonella Testing Market, By Testing Method, By Sample Type, By Application, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，沙門氏菌檢測市場規模將達到 39.3 億美元，到 2033 年將達到 67.4 億美元。預計 2026 年至 2033 年的複合年成長率將達到 8.0%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	39.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.00%	2033年市場規模預測：	67.4億美元

沙門氏菌是一類會引起人類全身性疾病（非傷寒沙門氏菌病）的細菌，也是全球食源性中毒的主要原因之一。這類細菌具有複雜的生理功能，使其能夠利用多種營養物質，從而在各種環境中生存。此外，沙門氏菌還能適應環境壓力，利用複雜的致病機制逃避免疫反應。

市場動態

在全球範圍內，大多數食物中毒病例是由沙門氏菌引起的。沙門氏菌疫情的增加引發了民眾對健康的擔憂，也因此推動了沙門氏菌檢測的需求。快速且準確的檢測對於識別受污染食品、實施必要的召回以及防止疾病進一步傳播至關重要。

對於食品企業，尤其是中小企業而言，實施沙門氏菌檢測方案和維護檢測設施成本高。試劑、檢測設備和合格人員的初始成本可能相當可觀。此外，維護和更新檢測系統以及遵守相關法規的持續成本也會限制全面實施沙門氏菌檢測計畫。

本研究的主要特點：

這項研究揭示了各個細分市場的潛在成長機會，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球沙門氏菌檢測市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球沙門氏菌檢測市場》報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球沙門氏菌檢測市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 南非
- 中非

第10章競爭格局

Thermo Fisher Scientific
Vitrosens Biotechnology
Merck KGaA
bioMA（C）rieux SA
Neogen Corporation
QIAGEN NV
3M
PerkinElmer Inc.
Romer Labs Division Holding GmbH
Eurofins Scientific
Hardy Diagnostics
Charles River Laboratories
LabCorp
R-Biopharm AG
Biomerica, Inc.

第11章

調查方法
關於本公司

簡介目錄

Product Code: CMI6013

Salmonella Testing Market is estimated to be valued at USD 3.93 Bn in 2026 and is expected to reach USD 6.74 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.93 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.00%	2033 Value Projection:	USD 6.74 Bn

The genus Salmonella is a group of bacteria that causes human systemic disease (non-typhoid salmonellosis), and they are one of the leading causes of foodborne illness in the world. They are able to survive in different environments because of their complex physiology that allows them to use various nutrient sources. Salmonella is also able to adapt to environmental stresses and can overcome immune responses by using sophisticated virulence mechanisms.

Market Dynamics

All around the world, foodborne diseases are frequently caused by salmonella. The demand for Salmonella testing is being driven by the increase in Salmonella outbreaks, which is causing public health concerns. In order to identify contaminated food products, launch necessary recalls, and stop the spread of illnesses further, quick and precise testing is essential.

It can be expensive for food companies to implement testing protocols for salmonella and to maintain testing facilities, especially for small and medium-sized businesses (SMEs). Initial costs for reagents, testing tools, and qualified employees might be high. The implementation of thorough Salmonella testing programs can be constrained by the continuing costs related to maintaining and updating testing systems and complying with regulatory regulations.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global salmonella testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Vitrosens Biotechnology, Merck KGaA, bioMerieux SA, Neogen Corporation, QIAGEN N.V., 3M, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories, LabCorp, R-Biopharm AG, and Biomerica Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global salmonella testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global salmonella testing market

Detailed Segmentation:

By Testing Method (Revenue, USD Bn, 2021 - 2033)
Culture-based Methods
Molecular-based Methods
Immunoassays
By Sample Type (Revenue, USD Bn, 2021 - 2033)
Food
Water
Environmental Surfaces
By Application (Revenue, USD Bn, 2021 - 2033)
Clinical Diagnostics
Food Safety Testing
Veterinary Diagnostics
By End User (Revenue, USD Bn, 2021 - 2033)
Food Producers and Manufacturers
Contract Testing Laboratories
Government and Regulatory Bodies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
By Company (Revenue, USD Bn, 2021 - 2033)
Thermo Fisher Scientific
Vitrosens Biotechnology
Merck KGaA
bioMerieux SA
Neogen Corporation
QIAGEN N.V.
3M
PerkinElmer Inc.
Romer Labs Division Holding GmbH
Eurofins Scientific
Hardy Diagnostics
Charles River Laboratories
LabCorp
R-Biopharm AG
Biomerica, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Salmonella Testing, By Testing Method
- Market Salmonella Testing, By Sample Type
- Market Salmonella Testing, By Application
- Market Salmonella Testing, By End User
- Market Salmonella Testing, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing Incidence of Salmonella Outbreaks
- Restraints
  - High Costs of Salmonella Testing
- Opportunities
  - Expansion in Emerging Markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Merger and Acquisition Scenario

4. Salmonella Testing

Supply Side and Demand Side Analysis
Economic Impact

5. Salmonella Testing Market, By Testing Method, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Culture-based Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Molecular-based Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Salmonella Testing Market, By Sample Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Food
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Water
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Environmental Surfaces
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Salmonella Testing Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Food Safety Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Veterinary Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Salmonella Testing Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Food Producers and Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Contract Testing Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Government and Regulatory Bodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Salmonella Testing Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing Method, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - North Africa
  - South Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vitrosens Biotechnology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
bioMA(C)rieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Neogen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Romer Labs Division Holding GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hardy Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
LabCorp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
R-Biopharm AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biomerica, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views